raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:873

Desmoid tumor

Synonyms: Aggressive fibromatosis · Desmoid type fibromatosis

Type
Disease
Group
Disorder
Inheritance
Not applicable, Unknown
Age of onset
Adolescent, Adult
Status
active

A desmoid tumor (DT) is a benign, locally invasive soft tissue tumor associated with a high recurrence rate but with no metastatic potential.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enDesmoid tumorAggressive fibromatosis · Desmoid type fibromatosis
frTumeur desmoïdeFibromatose agressive · Fibromatose type desmoïde
deDesmoidtumorDesmoid-Fibromatose · Fibromatose, aggressive
esTumor desmoideFibromatosis agresiva · Fibromatosis tipo desmoide
itTumore desmoideFibromatosi aggressiva · Fibromatosi, tipo desmoide
nlDesmoïde tumorAgressieve fibromatose · Desmoïd-type fibromatose
ptDoença desmóideFibromatose agressiva
plGuz desmoidalnyFibromatoza agresywna · Fibromatoza typu desomidalnego
csDesmoidní tumorAgresivní fibromatóza · Desmoidní typ fibromatózy
ukДесмоїдна пухлинаАгресивний фіброматоз · Фіброматоз десмоїдного типу
zh韧带样纤维瘤韧带样型纤维瘤病
trDesmoid tümörAgresif fibromatoz · Desmoid tipi fibromatoz

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM135290BTNTvalidated
ICD-10D48.1NTBTindexvalidated
ICD-112F7CNTBTattributedvalidated
ICD-11XH13Z3Especificvalidated
MONDO0007608Evalidated
UMLSC0079218Evalidated
GARD1820Evalidated
MedDRA10059352Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

2 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
APCDisease-causing somatic mutation(s) inAssessedHGNC:583ENSG000001349826117315q22.2APC regulator of Wnt signaling pathway
CTNNB1Disease-causing somatic mutation(s) inAssessedHGNC:2514ENSG000001680361168063p22.1catenin beta 1
5

Prevalence and incidence

3 records
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 1 000 0000.3 / 100 000EuropeValue and classValidated[EXPERT]
Annual incidence1-9 / 1 000 0000.33 / 100 000FinlandValue and classNot yet validated3946757[PMID]
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

20 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0004298Abnormality of the abdominal wall
HP:0003011Abnormality of the musculature
HP:0100245Desmoid tumors
HP:0010614Fibroma
HP:0001482Subcutaneous nodule
Frequent (79-30%)
HP:0002027Abdominal pain
HP:0007703Abnormality of retinal pigmentation
HP:0200008Intestinal polyposis
HP:0002024Malabsorption
HP:0003326Myalgia
Occasional (29-5%)
HP:0010935Abnormality of the upper urinary tract
HP:0002829Arthralgia
HP:0100749Chest pain
HP:0002239Gastrointestinal hemorrhage
HP:0000126Hydronephrosis
HP:0005214Intestinal obstruction
HP:0001376Limitation of joint mobility
HP:0008069Neoplasm of the skin
HP:0002797Osteolysis
HP:0100806Sepsis

Run the differential on the 5 obligate / very frequent terms

7

Sources for this card